-+ 0.00%
-+ 0.00%
-+ 0.00%

ENTERA BIO - EB613 PHASE 3 STUDY INITIATION PLANNED FOR LATE 2026, TOPLINE DATA ANTICIPATED IN SECOND HALF 2028

Reuters·08/07/2026 20:05:01

Please log in to view news